Article PDF
References
Steiner M, Reinhardt KM, Krammer B, Ernst B, Blann AD (1994) Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control. Thromb Haemost 72: 979–984
Cominacini L, Fratta Pasini A, Garbin U et al. (1995) Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia 38: 1122–1124
Blann AD, Tse W, Maxwell SJR, Waite MA (1994) Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. J Hypertension 12: 925–928
Cominacini L, Garbin U, Pastorino M et al. (1993) Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease. Atherosclerosis 99: 63–70
Cominacini L, Garbin U, Pastorino AM et al. (1994) Increased susceptibility of LDL to in vitro oxidation in patients with insulin-dependent and non-insulin-dependent diabetes mellitus. Diab Res 26: 173–184
Schwenke DC, Carew TE (1987) Determination of the LDL degradation rate, content and residence time in lesioned and non lesioned aorta. Circulation 76 [Suppl IV]: 313
Palinsky W, Yla-Herttuala S, Rosenfeld ME, Butler SW, Socher SA, Parthasarathy S (1990) Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 10: 325–332
Liao F, Berliner JA, Mehrabian M et al. (1991) Minimally modified low density lipoprotein is biologically active in vivo in mice. J Clin Invest 87: 2253–2257
Khan BV, Parthasarathy S, Alexander RW, Medford RM (1995) Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 95: 1262–1270
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cominacini, L., Garbin, U., Fratta Pasini, A. et al. Increased levels of plasma ELAM-1, ICAM-1 and VCAM-1 in NIDDM: possible role of oxidized LDL. Diabetologia 39, 1244 (1996). https://doi.org/10.1007/BF02658519
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02658519